These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 11059441)

  • 1. Efficacy of newer medications for treating depression in primary care patients.
    Mulrow CD; Williams JW; Chiquette E; Aguilar C; Hitchcock-Noel P; Lee S; Cornell J; Stamm K
    Am J Med; 2000 Jan; 108(1):54-64. PubMed ID: 11059441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
    Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amitriptyline versus other types of pharmacotherapy for depression.
    Guaiana G; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2003; (2):CD004186. PubMed ID: 12804503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amitriptyline for depression.
    Guaiana G; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004186. PubMed ID: 17636748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
    MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.
    Mittmann N; Herrmann N; Einarson TR; Busto UE; Lanctôt KL; Liu BA; Shulman KI; Silver IL; Narango CA; Shear NH
    J Affect Disord; 1997 Dec; 46(3):191-217. PubMed ID: 9547117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of treatment of depression.
    Broquet KE
    South Med J; 1999 Sep; 92(9):846-56. PubMed ID: 10498158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St John's wort for depression.
    Linde K; Mulrow CD; Berner M; Egger M
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000448. PubMed ID: 15846605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study.
    Parker G; Roy K; Wilhelm K; Mitchell P
    J Clin Psychiatry; 2001 Feb; 62(2):117-25. PubMed ID: 11247097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.